Helya Aghazdeh BSc, MD

Uczestniczy w 3 elementy

Elementy, w których Helya Aghazdeh BSc, MD uczestniczy

niedziela 3 czerwiec, 2018

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
11:40
Surgical management in the treatment of heavy eye syndrome: Success of myopexia alone without surgery for the medial rectus
11:43 - 11:50 | 7 min.

czwartek 13 czerwiec, 2019

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
14:00
Extraocular muscle imaging in strabismus
14:00 - 14:50 | 50 min.
Allied Health

piątek 10 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
12:40
Effect of Apraclonidine on Eyelid Position and Use in Surgical Planning
Halifax Convention Centre - C2
12:44 - 12:51 | 7 min.
Oculoplastics

Authors: Helya Aghazadeh, Audrey Chan. Author Disclosure Block: H. Aghazadeh: None. A. Chan: None.Abstract Body:Purpose: To investigate the role and reliability of apraclonidine (brand name Iopidine) eye drops in assessment of ptosis and surgical planning for ptosis repair.Study Design: This study is designed as a retrospective chart review.Methods: A ret...

Elementy, w których Helya Aghazdeh BSc, MD attends

czwartek 9 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
7:20
Uveal Melanoma 2022: Early Detection, Nanoparticle Therapy, and Systemic Immunotherapy.
7:20 - 7:45 | 25 min.
Pathology
8:20
Identifying Candidate Features of Uveal Melanoma for the Development of Machine Learning Algorithms.
8:20 - 8:30 | 10 min.
Pathology
14:20
The Business of Ophthalmology: How to run a Solo Practice
14:20 - 15:00 | 40 min.
Young Ophthalmologists and Residents
15:05
The Business of Ophthalmology: How to be an Entrepreneur
15:05 - 15:45 | 40 min.
Young Ophthalmologists and Residents